Rothschild Investment LLC Monte Rosa Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 50 shares of GLUE stock, worth $245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 120
58.33%
Holding current value
$245
Previous $833,000
72.15%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GLUE
# of Institutions
104Shares Held
53.5MCall Options Held
276KPut Options Held
15.9K-
Nea Management Company, LLC Timonium, MD7.69MShares$37.8 Million3.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.12MShares$34.9 Million0.01% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$27.8 Million58.01% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$24.1 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.35MShares$21.3 Million0.44% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $229M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...